
Fluoxetine as a Quit Smoking AID for Depression Prone
Cardiovascular DiseasesHeart DiseasesTo test whether adding fluoxetine pharmacotherapy to behavioral cessation treatment improves the depression-prone smoker's ability to quit.

Improving Coronary Prevention in a County Health System
Cardiovascular DiseasesCoronary Disease2 moreTo examine whether the Stanford Health Education and Risk Reduction Training (HEAR2T) program , a case management approach, can be effectively used to manage the risk of coronary artery disease.

Adherence to Weight Loss for Hypertension in African American Women
Cardiovascular DiseasesHeart Diseases2 moreTo develop a culturally tailored intervention intended to promote adherence to nutrition and physical activity regimens designed to result in weight loss for African American women.

Examining Psychosocial Mediators of Exercise Behavior
Cardiovascular DiseasesHeart DiseasesThe purpose of this study is to examine psychosocial mediators of exercise behavior.

Promoting Activity and Changes in Eating (PACE) to Reduce Obesity
ObesityCardiovascular Diseases1 moreReducing the prevalence of obesity in the population is one of the Healthy People 2010 goals. Increased vigilance is required in all age groups in preventing and reversing overweight and obesity. On an individual level, behavioral factors that influence body weight include eating choices leading to excess calorie intake and physical activity patterns leading to diminished calorie expenditure. An imbalance between the two over time leads to increased weight. On a population basis, the prevalence of overweight is associated with a myriad of influences, including social, behavioral, cultural, and environmental factors as well as genetic and physiological factors. For a majority of overweight individuals, restoring a balance between energy intake and expenditure is difficult, and therefore there is an increasing emphasis on preventing obesity on a population level. The long-term goal of this research is to prevent further increase in rates of obesity in the population. In the adult population of working age, a majority of the day is spent in the worksite, suggesting that interventions at the worksite level may offer the opportunity for success in this age group. It is anticipated that this project will yield important contributions to the understanding of obesity prevention.

OmniHeart Trial: Macronutrients and Cardiovascular Risk
Cardiovascular DiseasesHeart Diseases2 moreTo compare the effects on blood pressure and plasma lipids of three different diets--a carbohydrate-rich diet, a protein-rich diet, or a diet rich in unsaturated fat.

Sodium Sensitivity in African Americans
Cardiovascular DiseasesHeart Diseases2 moreTo compare the effects of two levels of dietary sodium on blood pressure in Black men and women, and to determine what factors predict the degree of response.

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Cardiovascular DiseasesCoronary Disease7 moreTo determine if the combined incidence of nonfatal myocardial infarction and coronary heart disease death differs between diuretic-based and each of three alternative antihypertensive pharmacological treatments. Also, to determine, in a subset of this population, if lowering serum cholesterol with a HMG CoA reductase inhibitor in older adults reduces all-cause mortality compared to a control group receiving usual care. Conducted in conjunction with the Department of Veterans' Affairs.

Girls Health Enrichment Multi-Site Studies (GEMS)
Cardiovascular DiseasesHeart Diseases1 moreTo develop and test interventions to prevent obesity by decreasing weight gain during the high-risk transitional period from pre-puberty to puberty in African-American girls who are at high risk for developing obesity.

Azithromycin and Coronary Events Study (ACES)
Coronary DiseaseHeart Diseases2 moreTo determine whether treatment with azithromycin decreases the rate of coronary heart disease events among patients with stable documented coronary artery disease.